CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
Merck & Co., Inc.  (MRK)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 
Prv. Close: $ 62.61 52 Wk High: $ 66.80
Week Perf: 0.32 % 52 Wk Avg: 62.72
30 Day Perf: -5.17 % 52 Wk Low: 57.18
Stock Price missing? Click here for Java troubleshoot
  MRK Charts & Quotes
You need to upgrade your Flash Player

 Market Capitalization (Millions $) 173,407
 Shares Outstanding (Millions) 2,770
 Employees 70,000
 Revenues (TTM) (Millions $) 39,929
 Net Income (TTM) (Millions $) 4,367
 Cash Flow (TTM) (Millions $) 1,992
 Capital Exp. (TTM) (Millions $) 1,674
Merck & Co., Inc.
Merck & Co., Inc., is a global research-driven pharmaceutical products company that discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. The Company sells its products primarily to drug wholesalers and retailers, hospitals, clinics, government agencies and managed health care providers such as health maintenance organizations and other institutions. The Company’s professional representatives communicate the effectiveness, safety and value of its products to health care professionals in private practice, group practices and managed care organizations.


 

Merck's Segments
 
Zocor
 Segment    0.57 % of total Revenue
Zetia
 Segment    6.48 % of total Revenue
CozaarHyzaar
 Segment    1.54 % of total Revenue
Singulair
 Segment    2.06 % of total Revenue
Proscar
 Segment    0.42 % of total Revenue
Isentress
 Segment    3.86 % of total Revenue
Primaxin
 Segment    0.77 % of total Revenue
Remicade
 Segment    4.52 % of total Revenue
Januvia
 Segment    10.38 % of total Revenue
Cancidas
 Segment    1.42 % of total Revenue
Other
 Segment    59.33 % of total Revenue
Merck Pharmaceutical
 Segment    91.34 % of total Revenue
Vaccines
 Segment    11.28 % of total Revenue
All Other
 Segment    8.66 % of total Revenue
 
  Company Estimates  
  Revenue Outlook
Merck announced annual revenue outlook on Jul. 28, 2015

Earnings Outlook
Merck & Co., Inc. issued annual earnings guidance on Jul. 28, 2015

 
Geographic Revenue Dispersion
United States 40.42 %
EMEA 31.19 %
Japan 8.22 %
Other 3.36 %
Asia Pacific 9.35 %
Latin America 7.46 %

Hexcel Corp

Double Digit EPS Growth, Sales Lower

Despite soft demand in the first quarter, company has managed to raise it's earnings per share, income increased by 18.64 % to $0.70 per share while Sales fell by -3.8 % to $478.80 millions, year on year.

Colgate Palmolive Co

Deterioration in Earnings, Sales Down Slightly

Colgate Palmolive Co announced disappointing results, eps deteriorated by -11.94 % to $0.59 from $0.67 and Sales declined by -0.49 % to $3.83 billions in the second quarter, year on year.


MRK's Valuation Current
Price to Earnings PE Ratio (TTM) 40.20
Price to Earnings PE Ratio (Expected) 38.77
Price to Sales (TTM) 4.34
Price to Sales (Expected) 4.44
Price to Book 4.33
PEG (TTM) -
MRK's Financial Strength Current
Quick Ratio 0.77
Working Capital Ratio 1.59
Leverage Ratio (MRQ) 1.41
Total Debt to Equity 0.71
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.39
Per Share Current
Earnings (TTM) 1.56 $
Revenues (TTM) 14.42 $
Cash Flow (TTM) 0.72 $
Cash 5.51 $
Book Value 14.47 $
Dividend (TTM) 1.85 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
MRK's Efficiency Current
Revenue per Employee (TTM) 570,414
Net Income per Employee (TTM) 62,386
Receivable Turnover Ratio (TTM) 5.63
Inventory Turnover Ratio (TTM) 2.6
Asset Turnover Ratio (TTM) 0.41
MRK's Profitability Ratio Current
Gross Margin 68.04 %
Operating Margin 21.85 %
Net Margin 16.49 %
Net Cash Flow Margin 55.05 %
Effective Tax Rate (TTM) 13.32 %
Management Effectiveness Current
Return On Assets (TTM) 4.52 %
Return On Investment (TTM) 5.46 %
Return On Equity (TTM) 10.41 %
Dividend Yield 3 %
Payout Ratio (TTM) 118.78 %
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


   
Customers Net Income fell by MRK's customers Net margin fell to %
-4.24 % 3.7 %
   
• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers
You need to upgrade your Flash Player


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
MYL        0.03% 
LLY        1.49% 
JNJ        0.73% 
CELG        2.2% 
BMY        1.51% 
ABT        4.27% 
• View Complete Report
   



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com